CTOs on the Move

Beth Abraham Health Services

www.bethabe.org

 
Beth Abraham Health Services is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bronx, NY. To find more information about Beth Abraham Health Services, please visit www.bethabe.org
  • Number of Employees: 0-25
  • Annual Revenue: $100-250 Million
  • www.bethabe.org
  • 612 Allerton Ave
    Bronx, NY USA 10467-7404
  • Phone: 718.881.3000

Executives

Name Title Contact Details

Similar Companies

Peninsula Community Mental Health Center

Peninsula Community Mental Health Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Peninsula Community Mental Health Center is based in Port Angeles, WA. You can find more information on Peninsula Community Mental Health Center at www.pcmhc.org

Urology Associates of North texas

Urologist Dallas Texas Medical City Hospital Robotic and Laparoscopic Surgery Prostate and Kidney UANT Urology Associates of North Texas Richard Bevan-Thomas MD enlarged prostate treatment vasectomy incontinence Dallas Plano Mesquite Garland Richardson

FDB

First Databank is a major provider of drug and medical device databases that help inform healthcare professionals to make decisions.

GeoH

Indianapolis-based GeoH is a Software as a Service (SaaS) company that provides an end-to-end home care software solution. The company was named one of the Top Ten Home Healthcare Solutions Providers in 2020 by Healthcare Tech Outlook. The company was created by agency owners and technologists with more than 20 years of experience working in home health care and technology.

Diagnocure

DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.